{"id":{"repo_id":"brazil-ufpb","oai_identifier":"oai:repositorio.ufpb.br:123456789/886"},"canonical_url":"https://search.dev.ndltd.org/etd/brazil-ufpb/oai:repositorio.ufpb.br:123456789/886","repository":{"repo_id":"brazil-ufpb","name":"Brazil UFPB","base_url":"https://repositorio.ufpb.br/oai/request"},"display":{"title":"Interferência de medicamentos em exames laboratoriais.","abstract":"Laboratory tests are important for the prevention and diagnosis of disease, aid in the treatmen t of diseases, monitoring of patients to verify the efficacy of the applied treatment and determine epidemiological data. The interference of drugs in tests performed in clinical and toxicological analysis is of paramount importance in routine laboratory t ests to interfere in and modify the clinical laboratory diagnosis, which leads to a negative false or positive f alse result, pseudo - increase or pseudo - decrease . The misdiagnosis can lead to serious health risks to patients, new clinical trials, that resul t in additional costs being so necessary. The probability of interference occurring increases as the patient uses more than one drug, which should always be checked by health professionals before the examinations. Note that the study of these important cha nges in laboratory reports by health professionals, primarily by analysts responsible for clinical laboratories.","abstract_html":"Laboratory tests are important for the prevention and diagnosis of disease, aid in the treatmen t of diseases, monitoring of patients to verify the efficacy of the applied treatment and determine epidemiological data. The interference of drugs in tests performed in clinical and toxicological analysis is of paramount importance in routine laboratory t ests to interfere in and modify the clinical laboratory diagnosis, which leads to a negative false or positive f alse result, pseudo - increase or pseudo - decrease . The misdiagnosis can lead to serious health risks to patients, new clinical trials, that resul t in additional costs being so necessary. The probability of interference occurring increases as the patient uses more than one drug, which should always be checked by health professionals before the examinations. Note that the study of these important cha nges in laboratory reports by health professionals, primarily by analysts responsible for clinical laboratories.","abstract_has_math":false,"creators":["Moura, José Anderson Pereira de"],"institution":"Universidade Federal da Paraíba","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-02-26","date_published":"2015-02-26","updated_at":"2026-07-24T01:18:03Z","subjects":["Interferência","Exames","Medicamentos"],"languages":["pt"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://repositorio.ufpb.br/jspui/handle/123456789/886","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Moura, José Anderson Pereira de"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-02-26T11:48:49Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-02-26T11:48:49Z"]},{"key":"dc:date.issued","label":"Date","values":["2015-02-26"]},{"key":"dc:publisher","label":"Institution","values":["Universidade Federal da Paraíba"]},{"key":"dc:type","label":"Dc Type","values":["TCC"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Interferência","Exames","Medicamentos"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["pt"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://repositorio.ufpb.br/jspui/handle/123456789/886"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Laboratory tests are important for the prevention and diagnosis of disease, aid in the treatmen t of diseases, monitoring of patients to verify the efficacy of the applied treatment and determine epidemiological data. The interference of drugs in tests performed in clinical and toxicological analysis is of paramount importance in routine laboratory t ests to interfere in and modify the clinical laboratory diagnosis, which leads to a negative false or positive f alse result, pseudo - increase or pseudo - decrease . The misdiagnosis can lead to serious health risks to patients, new clinical trials, that resul t in additional costs being so necessary. The probability of interference occurring increases as the patient uses more than one drug, which should always be checked by health professionals before the examinations. Note that the study of these important cha nges in laboratory reports by health professionals, primarily by analysts responsible for clinical laboratories."]},{"key":"dc:title","label":"Title","values":["Interferência de medicamentos em exames laboratoriais."]}]}],"canonical_facts":{"dc:creator":["Moura, José Anderson Pereira de"],"dc:date.accessioned":["2015-02-26T11:48:49Z"],"dc:date.available":["2015-02-26T11:48:49Z"],"dc:date.issued":["2015-02-26"],"dc:description.abstract":["Laboratory tests are important for the prevention and diagnosis of disease, aid in the treatmen t of diseases, monitoring of patients to verify the efficacy of the applied treatment and determine epidemiological data. The interference of drugs in tests performed in clinical and toxicological analysis is of paramount importance in routine laboratory t ests to interfere in and modify the clinical laboratory diagnosis, which leads to a negative false or positive f alse result, pseudo - increase or pseudo - decrease . The misdiagnosis can lead to serious health risks to patients, new clinical trials, that resul t in additional costs being so necessary. The probability of interference occurring increases as the patient uses more than one drug, which should always be checked by health professionals before the examinations. Note that the study of these important cha nges in laboratory reports by health professionals, primarily by analysts responsible for clinical laboratories."],"dc:identifier.uri":["https://repositorio.ufpb.br/jspui/handle/123456789/886"],"dc:language.iso":["pt"],"dc:publisher":["Universidade Federal da Paraíba"],"dc:subject":["Interferência","Exames","Medicamentos"],"dc:title":["Interferência de medicamentos em exames laboratoriais."],"dc:type":["TCC"]},"updated_at":"2026-07-24T01:18:03Z"}